Mineralys Therapeutics, Inc. (NASDAQ: MLYS), a clinical-stage biopharmaceutical company based in Radnor, Pennsylvania, has announced its participation in the upcoming Goldman Sachs 45th Annual Global Healthcare Conference. This event will take place in Miami, Florida, from June 10 to June 13, 2024. Mineralys Therapeutics specializes in developing treatments for hypertension, chronic kidney disease (CKD), and other conditions driven by dysregulated aldosterone.
Conference Details
Mineralys' management is scheduled to engage in a fireside chat during the conference. The details for the chat are as follows:
- Date: Tuesday, June 11, 2024
- Time: 4:00 PM EDT
- Format: Fireside Chat
- Webcast: A live webcast will be available in the "News and Events" section of the Investor Relations page on Mineralys' website. A replay will be accessible for approximately 90 days post-event.
About Mineralys Therapeutics
Mineralys Therapeutics is dedicated to advancing its pipeline of medicines aimed at treating hypertension, CKD, and other diseases linked to dysregulated aldosterone levels. Their lead product candidate, lorundrostat, is a proprietary, orally administered aldosterone synthase inhibitor being developed for cardiorenal conditions like hypertension and CKD. The company was established by Catalys Pacific and operates out of Radnor, Pennsylvania.
Accessing the Webcast
Interested parties can access the live webcast of the fireside chat through Mineralys' website under the Investor Relations section. The webcast will provide an opportunity to hear insights from Mineralys' management regarding their progress and future plans.
Conclusion
Mineralys Therapeutics continues to make strides in developing innovative treatments for significant health conditions. Their participation in the Goldman Sachs 45th Annual Global Healthcare Conference underscores their commitment to advancing their clinical programs and engaging with the broader healthcare community.
How to obtain the latest research advancements in the field of biopharmaceuticals?
In the Synapse database, you can keep abreast of the latest research and development advances in drugs, targets, indications, organizations, etc., anywhere and anytime, on a daily or weekly basis. Click on the image below to embark on a brand new journey of drug discovery!